Biotech Cnbc Experiencing Gilead Hep Hepatitis Kayla Patients Plummets Relapse Tausche Treated
CNBC's Kayla Tausche has the story on the biotech firm finding some patients treated with its Hepatitis C drug experiencing a relapse. (CNBC)
MSNBC | February 17, 2012
Tags:. .tausche. .hep. .gilead. .biotech. .kayla